Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10118931 CARM1 inhibitors and uses thereof

Patent 10118931 was granted and assigned to Epizyme on November, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Lei Jin0

Richard Chesworth0

Robert E. Babine0

Gideon Shapiro0

Oscar Miguel Moradei0

Date of Patent

November 6, 2018

Patent Application Number

15835758

Date Filed

December 8, 2017

Patent Citations Received

US Patent 12134620 Heterocyclic spiro compounds and methods of use thereof for the treatment of cancer

0

US Patent 11059819 Fused hetero-hetero bicyclic compounds and methods of use thereof

0

US Patent 11639346 Quinazoline derivatives as modulators of mutant KRAS, HRAS or NRAS

0

US Patent 11274093 Fused bicyclic benzoheteroaromatic compounds and methods of use thereof

0

US Patent 11279689 1-(3-(6-(3-hydroxynaphthalen-1-yl)benzofuran-2-yl)azetidin-1 yl)prop-2-en-1-one derivatives and similar compounds as KRAS G12C modulators for treating cancer

US Patent 11358959 Benzothiophene and benzothiazole compounds and methods of use thereof

US Patent 11377441 Covalent inhibitors of KRAS

US Patent 11834455 Carm1 inhibitors and uses thereof

0

...

Patent Primary Examiner

Patent abstract

Provided herein are compounds of Formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10118931 CARM1 inhibitors and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.